The goal of this study is to evaluate the effects of opioid antagonists on the hypothalamic-pituitary-gonadal axis in subjects with hypogonadotropic hypogonadism (HH).
The goal of this study is to evaluate the effects of opioid antagonists on the hypothalamic-pituitary-gonadal axis in subjects with hypogonadotropic hypogonadism (HH).
Opioid Antagonism in Hypogonadotropic Hypogonadism
-
Massachusetts General Hospital, Boston, Massachusetts, United States, 02114
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 75 Years
MALE
No
Stephanie B. Seminara, MD,
Stephanie Seminara, MD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital
2025-08-31